Qureight

Qureight is an imaging contract research organization that uses AI to analyze scans from clinical trials in lung and heart disease. Pharma and biotech sponsors use it to manage trial imaging and measure treatment response with automated endpoints.

Its curation platform onboards global trial sites, handles image quality control and central reads, and speeds up patient inclusion. Deep-learning lung biomarkers named Lung8, Air8, Fibr8, Glass8 and Vascul8 track response, predict progression and report baseline severity.

Therapeutic areas include idiopathic and progressive pulmonary fibrosis, pulmonary hypertension and bronchiectasis. Qureight also offers data science products built on access to large clinical imaging datasets, plus a key opinion leader advisory board.